ClonoSEQ Reference Testing Service
ID: W81K00-25-Q-A045Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M USA HCAJBSA FT SAM HOUSTON, TX, 78234-4504, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/289ce9da0d6544338118b420b053a099/view
Timeline
    Description

    The Department of Defense, specifically the Department of the Army, is planning to award a sole-source firm fixed contract for ClonoSEQ Reference Testing Services to Adaptive Biotechnologies Corporation. This procurement involves providing FDA-cleared in vitro diagnostic testing services, which include 15 genomic sequence analyses per year, and will be managed under FAR Part 13, Simplified Acquisition Procedures, covering a base year plus four optional years. These specialized medical laboratory services are crucial for maintaining medical readiness within the military. Interested providers must contact Colleen M. Rye by March 14, 2025, to demonstrate their capability to deliver the required services, as the award will be based on the lowest price/technically acceptable proposal, focusing exclusively on brand name products.

    Point(s) of Contact
    Colleen Rye
    colleen.m.rye.civ@health.mil
    Salameya Paulouskaya
    (210) 539-8656
    (210) 221-3446
    salameya.paulouskaya2.civ@health.mil
    Files
    Title
    Posted
    Notice of Intent to Sole Source.pdf
    The Medical Readiness Contracting Office-West plans to award a sole-source firm fixed contract to Adaptive Biotechnologies Corporation for ClonoSEQ FDA-cleared in vitro diagnostic testing services. This contract covers a base year plus four optional years, with the acquisition being managed through FAR Part 13, Simplified Acquisition Procedures. The procurement includes 15 assessments per year for genomic sequence analysis via multiplex PCR, specified in multiple contract line item numbers (CLINs). The NAICS code is 621511, and the PSC code is Q301. Interested providers should contact Colleen M. Rye by March 14, 2025, providing evidence of their capability to deliver the specified services. The award will be made based on the lowest price/technically acceptable proposal, emphasizing brand name products only. The document indicates that the government reserves the right to make decisions regarding competition based on the responses received, without an obligation to acknowledge submissions or provide feedback. This notice reflects the government's efforts to secure specialized medical laboratory services vital for maintaining medical readiness.
    Lifecycle
    Title
    Type
    ClonoSEQ Reference Testing Service
    Currently viewing
    Special Notice
    Similar Opportunities
    Notice of Intent to Sole Source
    Buyer not available
    The Department of Defense, through the Army Medical Research Acquisition Activity, intends to negotiate a sole source contract with Metabolon, Inc. for metabolomics analysis services over a five-year period, valued at approximately $3.96 million. The contract will support the U.S. Army Research Institute of Environmental Medicine by providing essential analyses of biological samples, including urine and blood, which are critical for ongoing and planned research studies. Metabolon is uniquely qualified to fulfill this requirement due to its extensive library of over 4,000 metabolites and advanced analytical capabilities, including ultra-high performance liquid chromatography-tandem-mass spectrometry (UPLC-MS/MS) and gas chromatography-mass spectrometry (GC-MS). Interested firms may express their capability by March 13, 2025, and should contact Kasey Carroll at kasey.l.carroll.civ@health.mil or Jennifer Bassett at jennifer.s.bassett.civ@health.mil for further information.
    Microbial Testing Supplies - Bridge Contract
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC), Germany
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking proposals for Clinical Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC) in Germany. The contract, identified by Solicitation Number W9114F25QA019, will cover a range of laboratory tests required from May 1, 2025, through April 30, 2026, with a focus on compliance with College of American Pathologists (CAP) standards and timely reporting of results within 72 hours. This procurement is crucial for maintaining healthcare service standards for military personnel, ensuring accurate and efficient laboratory testing. Interested contractors must submit their proposals, including pricing details and compliance with federal regulations, to the primary contact, Henning Mayer-Goldstein, at henningfalk.mayer-goldstein.ln@health.mil by the specified deadlines.
    6550--Lab Testing Services - (HIV/HCV/HPV/On)
    Buyer not available
    The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
    Notice of Intent to Sole Source ‘omics analyses
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), has issued a Special Notice regarding its intent to sole source ‘omics analyses services. The procurement aims to secure specialized research and development services in the life sciences sector, specifically focusing on health-related research and applied analysis. These services are critical for advancing health care solutions and enhancing the understanding of biological systems, which are vital for military health initiatives. Interested parties can reach out to Kasey Carroll at kasey.l.carroll.civ@health.mil or Courtney Piar at courtney.a.piar.civ@health.mil for further information regarding this opportunity.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
    Next Sequencing 2000 System
    Buyer not available
    The Department of Defense, through the Naval Medical Research Center, is soliciting proposals for the procurement of the NextSeq 2000 Sequencing System, specifically targeting women-owned small businesses (WOSB). This solicitation outlines the requirements for delivery, acceptance, and compliance with federal regulations, emphasizing firm fixed pricing and the need for unique identifiers for items valued at $5,000 or more. The NextSeq 2000 Sequencing System is crucial for advanced genomic research and analysis, supporting the Department's mission in medical research and development. Interested vendors should contact Deborah M. Sharpe at deborah.m.sharpe2.civ@health.mil or Stephanie Gray at Stephanie.Gray@med.navy.mil for further details, with submissions expected to adhere to the outlined guidelines and deadlines.
    5-Year UTARNG Lab Services Blanket Purchase Agreement (BPA)
    Buyer not available
    The Department of Defense, through the Utah Army National Guard (UTARNG), is seeking qualified small businesses to establish a 5-Year Blanket Purchase Agreement (BPA) for medical testing and laboratory services. The contractor will be responsible for providing a range of laboratory tests, including blood and urine analyses, metabolic panels, and immunology assays, with a total anticipated award amount of $41.5 million aimed at enhancing medical readiness for military personnel. This procurement is critical for ensuring timely and high-quality medical services that support the health of personnel, reflecting federal priorities for health readiness and small business participation. Interested parties can contact William T. Brown at william.t.brown68.civ@army.mil or by phone at 801-432-4273 for further details.
    Oncology breast testing
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking sources for oncology breast testing services. This procurement aims to identify qualified medical laboratories capable of providing specialized testing services critical for cancer diagnosis and treatment. The services will be performed in Bethesda, Maryland, and are essential for supporting the health and readiness of military personnel and their families. Interested parties can reach out to Edgar DuChemin at edgar.r.duchemin.civ@health.mil or call 703-275-6348 for further information regarding this opportunity.
    Q301-- Five (5) Full-Time Equivalent Certified Medical Technologists
    Buyer not available
    The Department of Veterans Affairs is seeking to procure the services of five full-time certified Medical Technologists to support the Public Health National Program Office. These professionals will be responsible for performing high-complexity molecular laboratory testing and laboratory information management services, which are critical for the nation's biodefense strategy and public health preparedness, particularly in diagnosing emerging pathogens and high-consequence infections. Interested vendors must respond with their company details and capabilities by March 13, 2025, with a preference for submissions from service-disabled veteran-owned and veteran-owned small businesses. For further inquiries, potential respondents can contact Contracting Officer Larry Facio at Larry.Facio@va.gov or by phone at 916-923-4553.